FUQIX
Price
$21.92
Change
-$0.38 (-1.70%)
Updated
Jun 13 closing price
Net Assets
20.95B
RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

FUQIX vs RGAGX

Header iconFUQIX vs RGAGX Comparison
Open Charts FUQIX vs RGAGXBanner chart's image
Fidelity SAI US Quality Index
Price$21.92
Change-$0.38 (-1.70%)
VolumeN/A
Net Assets20.95B
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
FUQIX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FUQIX vs. RGAGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FUQIX is a Buy and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. FUQIX (20.9B). FUQIX pays higher dividends than RGAGX: FUQIX (0.94) vs RGAGX (0.65). FUQIX was incepted earlier than RGAGX: FUQIX (10 years) vs RGAGX (16 years). RGAGX (0.30) is less costly to investors than FUQIX (0.11). FUQIX is a more actively managed with annual turnover of: 53.00 vs. RGAGX (25.00). FUQIX has a lower initial minimum investment than RGAGX: FUQIX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. FUQIX (-3.77). FUQIX return over 5 years is better than : 59.24 vs. RGAGX (51.11).
FUQIXRGAGXFUQIX / RGAGX
Total Expense Ratio0.110.3037%
Annual Report Gross Expense Ratio0.110.3037%
Fund Existence10 years16 years-
Gain YTD3.0085.20558%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets20.9B306B7%
Annual Yield % from dividends0.940.65144%
Returns for 1 year-3.777.67-49%
Returns for 3 years52.7254.6696%
Returns for 5 years59.2451.11116%
Returns for 10 yearsN/A75.62-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX124.39-0.62
-0.50%
Neurocrine Biosciences
NMIH40.34-0.26
-0.64%
NMI Holdings
PMCB1.01-0.01
-0.99%
PharmaCyte Biotech
GSBC55.62-1.83
-3.19%
Great Southern Bancorp
CXDO5.14-0.36
-6.55%
Crexendo